The biosimilar's safety and immunogenicity profiles were found to be comparable to those of the reference product in the ...
LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback